Trgovina Pieris Pharmaceuticals, Inc. - PIRS CFD
Dodaj med priljubljene- Povzetek
- Zgodovinski podatki
- Dogodki
- Izkaz poslovnega izida
- Bilanca stanja
- Denarni tok
- Lastništvo
Pogoji trgovanja
| Razmik | 0.05 | ||||||||
|
Nočna pristojbina za nakup
Long position overnight fee
Pojdi na platformo | -0.025457% | ||||||||
|
Nočna pristojbina za prodajo
Short position overnight fee
Pojdi na platformo | 0.003235% | ||||||||
| Čas nočne pristojbine | 21:00 (UTC) | ||||||||
| Min. tržena količina | 1 | ||||||||
| Valuta | USD | ||||||||
| Kritje | 20% | ||||||||
| Borza | United States of America | ||||||||
| Provizija na trgovanje | 0% |
*Information provided by Capital.com
Pieris Pharmaceuticals Inc ESG Risk Ratings
High Medium Low Negligible
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Ključni statistični podatki
| Predhodno. Zapri* | 0.73 |
| Odpri* | 0.76 |
| Enoletna sprememba* | -55.56% |
| Dnevni razpon* | 0.73 - 0.81 |
| Razpon 52 wk | 0.72-2.12 |
| Povprečni obseg (10 dni) | 743.53K |
| Povprečni obseg (3 meseci) | 13.81M |
| Tržna kapitalizacija | 61.51M |
| Razmerje P/E | -100.00K |
| Število delnic v obtoku | 82.02M |
| Prihodki | 16.85M |
| EPS | -0.56 |
| Dividenda (donosnost v %) | N/A |
| Beta | 1.08 |
| Datum naslednjega zaslužka | Aug 2, 2023 |
Vse podatke je zagotovil Refinitiv, razen podatkov, označenih z zvezdico, ki so *podatki, ki jih je zagotovil Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Zapiranje | Change | Change (%) | Odpiranje | High | Low |
|---|---|---|---|---|---|---|
| May 30, 2023 | 0.73 | -0.05 | -6.41% | 0.78 | 0.78 | 0.72 |
| May 26, 2023 | 0.72 | -0.08 | -10.00% | 0.80 | 0.85 | 0.72 |
| May 25, 2023 | 0.79 | -0.04 | -4.82% | 0.83 | 0.84 | 0.79 |
| May 24, 2023 | 0.85 | -0.02 | -2.30% | 0.87 | 0.88 | 0.84 |
| May 23, 2023 | 0.89 | -0.03 | -3.26% | 0.92 | 0.92 | 0.86 |
| May 22, 2023 | 0.84 | 0.02 | 2.44% | 0.82 | 0.84 | 0.77 |
| May 19, 2023 | 0.79 | -0.07 | -8.14% | 0.86 | 0.87 | 0.78 |
| May 18, 2023 | 0.83 | 0.02 | 2.47% | 0.81 | 0.94 | 0.79 |
| May 17, 2023 | 0.76 | 0.00 | 0.00% | 0.76 | 0.79 | 0.74 |
| May 16, 2023 | 0.77 | -0.05 | -6.10% | 0.82 | 0.82 | 0.77 |
| May 15, 2023 | 0.83 | 0.00 | 0.00% | 0.83 | 0.85 | 0.78 |
| May 12, 2023 | 0.84 | -0.08 | -8.70% | 0.92 | 0.92 | 0.82 |
| May 11, 2023 | 0.93 | 0.12 | 14.81% | 0.81 | 0.96 | 0.76 |
| May 10, 2023 | 0.84 | 0.06 | 7.69% | 0.78 | 0.84 | 0.75 |
| May 9, 2023 | 0.82 | 0.02 | 2.50% | 0.80 | 0.82 | 0.73 |
| May 8, 2023 | 0.80 | -0.02 | -2.44% | 0.82 | 0.84 | 0.79 |
| May 5, 2023 | 0.83 | 0.05 | 6.41% | 0.78 | 0.85 | 0.78 |
| May 4, 2023 | 0.77 | -0.03 | -3.75% | 0.80 | 0.84 | 0.74 |
| May 3, 2023 | 0.79 | 0.03 | 3.95% | 0.76 | 0.80 | 0.72 |
| May 2, 2023 | 0.74 | 0.03 | 4.23% | 0.71 | 0.74 | 0.70 |
Pieris Pharmaceuticals, Inc. Events
| Čas (UTC) (UTC) | Država | Dogodek |
|---|---|---|
| Wednesday, June 21, 2023 | ||
| Čas (UTC) (UTC) 12:00 | Država US
| Dogodek Pieris Pharmaceuticals Inc Annual Shareholders Meeting Pieris Pharmaceuticals Inc Annual Shareholders MeetingForecast -Previous - |
| Thursday, June 22, 2023 | ||
| Čas (UTC) (UTC) 12:00 | Država US
| Dogodek Pieris Pharmaceuticals Inc Annual Shareholders Meeting Pieris Pharmaceuticals Inc Annual Shareholders MeetingForecast -Previous - |
| Wednesday, August 2, 2023 | ||
| Čas (UTC) (UTC) 12:30 | Država US
| Dogodek Q2 2023 Pieris Pharmaceuticals Inc Earnings Release Q2 2023 Pieris Pharmaceuticals Inc Earnings ReleaseForecast -Previous - |
| Tuesday, October 31, 2023 | ||
| Čas (UTC) (UTC) 12:30 | Država US
| Dogodek Q3 2023 Pieris Pharmaceuticals Inc Earnings Release Q3 2023 Pieris Pharmaceuticals Inc Earnings ReleaseForecast -Previous - |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Skupni prihodki | 25.902 | 31.418 | 29.323 | 46.279 | 29.101 |
| Prihodki | 25.902 | 31.418 | 29.323 | 46.279 | 29.101 |
| Celotni odhodki iz poslovanja | 61.203 | 79.564 | 63.244 | 73.436 | 59.932 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 16.394 | 16.593 | 16.713 | 18.44 | 18.442 |
| Raziskave in razvoj | 52.982 | 66.656 | 46.531 | 54.996 | 41.49 |
| Prihodki iz poslovanja | -35.301 | -48.146 | -33.921 | -27.157 | -30.831 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 0.721 | 0.004 | 0.511 | 1.714 | 1.962 |
| Drugo, neto | 1.303 | 2.404 | -3.656 | -0.026 | 1.803 |
| Čisti dobiček pred obdavčitvijo | -33.277 | -45.738 | -37.066 | -25.469 | -27.066 |
| Čisti dobiček po davkih | -33.277 | -45.738 | -37.23 | -25.469 | -26.754 |
| Čisti dobiček pred dodatnimi postavkami | -33.277 | -45.738 | -37.23 | -25.469 | -26.754 |
| Čisti dobiček | -33.277 | -45.738 | -37.23 | -25.469 | -26.754 |
| Total Adjustments to Net Income | -2.83 | ||||
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -33.277 | -45.738 | -37.23 | -28.299 | -26.754 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -33.277 | -45.738 | -37.23 | -28.299 | -26.754 |
| Popravljen čisti dobiček | -33.277 | -45.738 | -37.23 | -28.299 | -26.754 |
| Popravljene ponderirane povprečne delnice | 74.172 | 64.547 | 54.481 | 50.625 | 53.081 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.44865 | -0.7086 | -0.68336 | -0.55899 | -0.50402 |
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.55884 | -0.76569 | -0.68336 | -0.55899 | -0.50402 |
| Skupaj izredne postavke | |||||
| Nenavadni odhodki (prihodki) | -8.173 | -3.685 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Skupni prihodki | 1.936 | 5.846 | 5.37 | 3.698 | 10.988 |
| Prihodki | 1.936 | 5.846 | 5.37 | 3.698 | 10.988 |
| Celotni odhodki iz poslovanja | 15.419 | 13.974 | 16.07 | 14.844 | 16.315 |
| Celotna prodaja/splošni/upravni stroški Odhodki | 4.023 | 3.985 | 3.949 | 4.081 | 4.379 |
| Raziskave in razvoj | 13.424 | 13.38 | 13.589 | 11.947 | 14.066 |
| Prihodki iz poslovanja | -13.483 | -8.128 | -10.7 | -11.146 | -5.327 |
| Prihodki (odhodki) od obresti, neto Neoperativni | 0.357 | 0.351 | 0.241 | 0.132 | -0.003 |
| Drugo, neto | -0.057 | -0.325 | 0.723 | 0.676 | 0.229 |
| Čisti dobiček pred obdavčitvijo | -13.183 | -8.102 | -9.736 | -10.338 | -5.101 |
| Čisti dobiček po davkih | -13.183 | -8.102 | -9.736 | -10.338 | -5.101 |
| Čisti dobiček pred dodatnimi postavkami | -13.183 | -8.102 | -9.736 | -10.338 | -5.101 |
| Čisti dobiček | -13.183 | -8.102 | -9.736 | -10.338 | -5.101 |
| Prihodek, ki je na razpolago navadnim delničarjem, brez dodatnih postavk | -13.183 | -8.102 | -9.736 | -10.338 | -5.101 |
| Prihodek, ki je na razpolago skupnemu dobičku, vključno z dodatnimi postavkami | -13.183 | -8.102 | -9.736 | -10.338 | -5.101 |
| Popravljen čisti dobiček | -13.183 | -8.102 | -9.736 | -10.338 | -5.101 |
| Popravljene ponderirane povprečne delnice | 74.519 | 74.448 | 74.397 | 74.125 | 73.711 |
| Popravljen dobiček na delnico brez upoštevanja izrednih postavk | -0.17691 | -0.10883 | -0.13087 | -0.13947 | -0.0692 |
| Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
| Popravljen normalizirani dobiček na enoto čistega dobička | -0.20412 | -0.15438 | -0.1506 | -0.15544 | -0.0981 |
| Nenavadni odhodki (prihodki) | -2.028 | -3.391 | -1.468 | -1.184 | -2.13 |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 73.424 | 127.625 | 75.721 | 115.013 | 135.382 |
| Denarna sredstva in kratkoročne naložbe | 59.169 | 117.764 | 70.436 | 104.154 | 128.107 |
| Denarna sredstva in ustrezniki | 38.635 | 117.764 | 70.436 | 62.26 | 74.867 |
| Celotne terjatve, neto | 5.81 | 3.313 | 1.706 | 6.787 | 2.701 |
| Accounts Receivable - Trade, Net | 5.81 | 3.313 | 1.706 | 6.787 | 2.701 |
| Prepaid Expenses | 8.445 | 6.548 | 3.579 | 4.072 | 4.574 |
| Total Assets | 95.49 | 153.56 | 105.01 | 141.097 | 141.341 |
| Property/Plant/Equipment, Total - Net | 20.697 | 23.031 | 25.98 | 22.938 | 5.049 |
| Property/Plant/Equipment, Total - Gross | 30.344 | 30.748 | 31.795 | 26.505 | 8.415 |
| Accumulated Depreciation, Total | -9.647 | -7.717 | -5.815 | -3.567 | -3.366 |
| Other Long Term Assets, Total | 1.369 | 2.904 | 3.309 | 3.146 | 0.91 |
| Total Current Liabilities | 36.583 | 50.561 | 22.145 | 27.003 | 48.076 |
| Accounts Payable | 4.154 | 8.609 | 1.787 | 5.803 | 3.35 |
| Accrued Expenses | 11.122 | 14.833 | 7.496 | 9.486 | 8.169 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 21.307 | 27.119 | 12.862 | 11.714 | 36.557 |
| Total Liabilities | 67.561 | 102.805 | 73.983 | 89.745 | 101.406 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 30.978 | 52.244 | 51.838 | 62.742 | 53.33 |
| Total Equity | 27.929 | 50.755 | 31.027 | 51.352 | 39.935 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.074 | 0.072 | 0.056 | 0.055 | 0.054 |
| Additional Paid-In Capital | 318.53 | 306.998 | 242.672 | 227.468 | 189.929 |
| Retained Earnings (Accumulated Deficit) | -290.421 | -257.144 | -211.406 | -174.176 | -147.066 |
| Other Equity, Total | -0.254 | 0.829 | -0.295 | -1.995 | -2.982 |
| Total Liabilities & Shareholders’ Equity | 95.49 | 153.56 | 105.01 | 141.097 | 141.341 |
| Total Common Shares Outstanding | 74.5191 | 72.2227 | 56.0028 | 55.2124 | 54.1512 |
| Kratkoročne naložbe | 20.534 | 0 | 41.894 | 53.24 | |
| Long Term Investments | 0 | ||||
| Total Preferred Shares Outstanding | 0.00762 | 0.00762 | 0.01443 | 0.01143 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Kratkoročna sredstva skupaj | 60.505 | 73.424 | 78.56 | 90.904 | 111.749 |
| Denarna sredstva in kratkoročne naložbe | 48.379 | 59.169 | 69.823 | 80.936 | 100.268 |
| Denarna sredstva in ustrezniki | 39.742 | 38.635 | 48.423 | 54.257 | 83.737 |
| Celotne terjatve, neto | 1.055 | 5.81 | 0.829 | 1.264 | 1.644 |
| Accounts Receivable - Trade, Net | 1.055 | 5.81 | 0.829 | 1.264 | 1.644 |
| Prepaid Expenses | 11.071 | 8.445 | 7.908 | 8.704 | 9.837 |
| Total Assets | 82.258 | 95.49 | 99.163 | 114.309 | 137.115 |
| Property/Plant/Equipment, Total - Net | 20.502 | 20.697 | 19.296 | 21.047 | 22.693 |
| Property/Plant/Equipment, Total - Gross | 30.476 | 30.344 | 27.615 | 29.292 | 30.87 |
| Accumulated Depreciation, Total | -9.974 | -9.647 | -8.319 | -8.245 | -8.177 |
| Other Long Term Assets, Total | 1.251 | 1.369 | 1.307 | 2.358 | 2.673 |
| Total Current Liabilities | 42.875 | 36.583 | 33.521 | 35.546 | 39.484 |
| Accounts Payable | 5.833 | 4.154 | 3.641 | 1.898 | 4.496 |
| Accrued Expenses | 9.764 | 11.122 | 10.801 | 10.175 | 11.858 |
| Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities, Total | 27.278 | 21.307 | 19.079 | 23.473 | 23.13 |
| Total Liabilities | 66.8 | 67.561 | 63.396 | 69.944 | 83.665 |
| Total Long Term Debt | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities, Total | 23.925 | 30.978 | 29.875 | 34.398 | 44.181 |
| Total Equity | 15.458 | 27.929 | 35.767 | 44.365 | 53.45 |
| Redeemable Preferred Stock | 0 | 0 | 0 | 0 | 0 |
| Common Stock | 0.074 | 0.074 | 0.074 | 0.074 | 0.074 |
| Additional Paid-In Capital | 319.414 | 318.53 | 317.488 | 316.249 | 314.668 |
| Retained Earnings (Accumulated Deficit) | -303.604 | -290.421 | -282.319 | -272.583 | -262.245 |
| Other Equity, Total | -0.426 | -0.254 | 0.524 | 0.625 | 0.953 |
| Total Liabilities & Shareholders’ Equity | 82.258 | 95.49 | 99.163 | 114.309 | 137.115 |
| Total Common Shares Outstanding | 74.5191 | 74.5191 | 74.4062 | 74.2576 | 74.0979 |
| Total Preferred Shares Outstanding | 0.00762 | 0.00762 | 0.00762 | 0.00762 | 0.00762 |
| Kratkoročne naložbe | 8.637 | 20.534 | 21.4 | 26.679 | 16.531 |
- Letni
- Četrtletno
| 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|
| Čisti prihodki/začetna postavka | -33.277 | -45.738 | -37.23 | -25.469 | -26.754 |
| Denarna sredstva iz poslovanja | -59.932 | -7.66 | -45.896 | -52.467 | -1.066 |
| Denarna sredstva iz poslovanja | 2.77 | 2.459 | 2.311 | 0.632 | 0.57 |
| Nedenarne postavke | 3.945 | 5.094 | 5.236 | 4.491 | 3.389 |
| Cash Taxes Paid | 0 | 0.908 | |||
| Denarna sredstva Plačane obresti | |||||
| Spremembe v obratnem kapitalu | -33.37 | 30.525 | -16.377 | -32.121 | 21.893 |
| Denarna sredstva pri naložbenju | -21.236 | -0.949 | 39.212 | 9.838 | -8.875 |
| Kapitalski izdatki | -1.041 | -0.949 | -2.726 | -2.462 | -1.698 |
| Celotne druge postavke denarnih tokov pri naložbenju | -20.195 | 0 | 41.938 | 12.3 | -7.177 |
| Denarna sredstva pri financiranju | 7.214 | 59.127 | 10.115 | 32.166 | 48.511 |
| Izdaja (odplačilo) delnic, neto | 7.017 | 58.962 | 9.915 | 31.797 | 48.511 |
| Učinki deviznih tečajev | -5.175 | -3.19 | 4.745 | -2.144 | -1.581 |
| Neto sprememba denarnih sredstev | -79.129 | 47.328 | 8.176 | -12.607 | 36.989 |
| Deferred Taxes | 0 | 0.164 | 0 | -0.164 | |
| Postavke denarnega toka pri financiranju | 0.197 | 0.165 | 0.2 | 0.369 |
| Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
|---|---|---|---|---|---|
| Net income/Starting Line | -13.183 | -33.277 | -25.175 | -15.439 | -5.101 |
| Cash From Operating Activities | -10.996 | -59.932 | -46.999 | -38.221 | -22.643 |
| Cash From Operating Activities | 0.605 | 2.77 | 2.195 | 1.428 | 0.845 |
| Non-Cash Items | 0.975 | 3.945 | 3.37 | 2.728 | 1.264 |
| Changes in Working Capital | 0.607 | -33.37 | -27.389 | -26.938 | -19.651 |
| Cash From Investing Activities | 11.903 | -21.236 | -22.343 | -27.813 | -16.948 |
| Capital Expenditures | -0.048 | -1.041 | -1.052 | -1.018 | -0.389 |
| Other Investing Cash Flow Items, Total | 11.951 | -20.195 | -21.291 | -26.795 | -16.559 |
| Cash From Financing Activities | 0 | 7.214 | 7.121 | 6.839 | 6.558 |
| Issuance (Retirement) of Stock, Net | 0 | 7.017 | 7.017 | 6.735 | 6.558 |
| Foreign Exchange Effects | 0.2 | -5.175 | -7.12 | -4.312 | -0.994 |
| Net Change in Cash | 1.107 | -79.129 | -69.341 | -63.507 | -34.027 |
| Financing Cash Flow Items | 0.197 | 0.104 | 0.104 | ||
| Deferred Taxes |
| Ime vlagatelja | Vrsta vlagatelja | Odstotek neporavnanih obveznosti | Delnice v lasti | Sprememba delnic | Datum imetništva | Ocena prometa |
|---|---|---|---|---|---|---|
| BVF Partners L.P. | Hedge Fund | 25.1281 | 20609863 | 15529543 | 2023-05-11 | LOW |
| Lynx1 Capital Advisors LLC | Investment Advisor | 8.6172 | 7067718 | 1439133 | 2023-03-31 | |
| Aquilo Capital Management, LLC | Investment Advisor/Hedge Fund | 5.551 | 4552876 | 0 | 2023-03-31 | |
| Soleus Capital Management, L.P. | Hedge Fund | 5.0413 | 4134868 | 134868 | 2023-03-31 | HIGH |
| Seagen Inc | Corporation | 4.5187 | 3706174 | 0 | 2022-12-31 | |
| AstraZeneca PLC | Corporation | 4.37 | 3584230 | 0 | 2022-12-31 | LOW |
| Pontifax Ltd. | Venture Capital | 4.3544 | 3571428 | 0 | 2021-12-31 | LOW |
| Marshall Wace LLP | Investment Advisor/Hedge Fund | 2.7632 | 2266350 | -125686 | 2023-03-31 | HIGH |
| Citadel Advisors LLC | Hedge Fund | 2.4383 | 1999907 | -46254 | 2023-03-31 | HIGH |
| Medical Strategy GmbH | Investment Advisor | 1.9744 | 1619387 | 52729 | 2023-01-31 | LOW |
| BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.4366 | 1178283 | -114163 | 2023-03-31 | LOW |
| The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 1.2626 | 1035540 | -29441 | 2023-03-31 | LOW |
| Platinum Asset Management | Investment Advisor/Hedge Fund | 1.1888 | 975012 | -245786 | 2023-03-31 | LOW |
| Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 0.769 | 630690 | -251144 | 2023-03-31 | MED |
| Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7681 | 629965 | 0 | 2023-03-31 | LOW |
| BMO Capital Markets (US) | Research Firm | 0.5873 | 481727 | 481727 | 2022-12-31 | MED |
| Walleye Capital LLC | Hedge Fund | 0.5839 | 478935 | 478935 | 2023-03-31 | LOW |
| Renaissance Technologies LLC | Hedge Fund | 0.4699 | 385391 | -301600 | 2023-03-31 | HIGH |
| Cutter & Company, Inc. | Investment Advisor | 0.4602 | 377479 | -1000 | 2023-03-31 | LOW |
| Candriam Belgium S.A. | Investment Advisor/Hedge Fund | 0.429 | 351834 | -590000 | 2023-03-31 | LOW |
Zakaj izbrati Capital.com? Številke govorijo same zase.
Capital.com Group530K+
Borzni posredniki
87K+
Aktivne stranke mesečno
$46M+
Mesečni obseg naložb
$31M+
Dvigi vsak mesec
Kalkulator trgovanja
Izračunajte svoj hipotetični P&L, če bi trgovino s CFD odprli na določen datum (izberite datum) in jo zaprli na drug datum (izberite datum).
Trgovalna provizija
0
- 1:1
Vzvod
1:1
- 20
- 100
- 500
- 1000
- 10000
Naložbe
Velikost posla (finančni vzvod x naložba):
Odpiranje
Zapiranje
Kratka Dolga
Pieris Pharmaceuticals, Inc. Company profile
O družbi Pieris Pharmaceuticals, Inc.
Pieris Pharmaceuticals, Inc. je biotehnološko podjetje v klinični fazi, ki odkriva in razvija zdravila na osnovi antikalina za zdravljenje potrjenih bolezenskih poti. Vodilni kandidat za zdravilo za dihala, ki temelji na anticalinu, je PRS-060/AZD1402, ki antagonizira IL-4R alfa, s čimer zavira IL-4 in IL-13, dva citokina, majhne beljakovine, ki posredujejo signale med celicami v človeškem telesu in so znani kot posredniki v vnetni kaskadi, ki povzročajo patogenezo astme in drugih vnetnih bolezni. Vodilni kandidat za zdravilo na osnovi IO Anticalin, ki je v pripravi, je cinrebafusp alfa, ki je zasnovan tako, da cilja na imunski receptor 4-1BB in tumorsko tarčo HER2. Cinrebafusp alfa je genetska fuzija različice protitelesa, usmerjenega proti HER2, z beljakovino Anticalin, specifično za 4-1BB.
| Industry: | Bio Therapeutic Drugs |
225 Franklin Street
26Th Floor
BOSTON
MASSACHUSETTS 02110
US
Izkaz poslovnega izida
- Annual
- Quarterly
Ljudje gledajo tudi
Še vedno iščete posrednika, ki mu lahko zaupate?
Pridružite se 530.000+ trgovcem po vsem svetu, ki so se odločili za trgovanje s Capital.com